FDA grants SeaStar Medical breakthrough device designation for SCD therapy

Oct 7 (Reuters) — SeaStar Medical Holding Corp: Fda Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition Source text:... Further company coverage: ICU.O (Reuters.Briefs@thomsonreuters.com;)